BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golan Y. Current Treatment Options for Acute Skin and Skin-structure Infections. Clin Infect Dis 2019;68:S206-12. [PMID: 30957166 DOI: 10.1093/cid/ciz004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Fathi HA, Abdelkader A, AbdelKarim MS, Abdelaziz AA, El-Mokhtar MA, Allam A, Fetih G, El Badry M, Elsabahy M. Electrospun vancomycin-loaded nanofibers for management of methicillin-resistant Staphylococcus aureus-induced skin infections. Int J Pharm 2020;586:119620. [PMID: 32652179 DOI: 10.1016/j.ijpharm.2020.119620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Bai F, Aldieri C, Cattelan A, Raumer F, Di Meco E, Moioli MC, Tordato F, Morelli P, Borghi F, Rizzi M, Van Hauwermeiren E, Castelli F, Migliorino G, Menzaghi B, Rizzardini G, Saracino A, Cascio A, Puoti M, d'Arminio Monforte A, Marchetti G. Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). Expert Rev Anti Infect Ther 2020;18:1271-9. [PMID: 32797758 DOI: 10.1080/14787210.2020.1798227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Vijaya Chandra SH, Srinivas R, Dawson TL Jr, Common JE. Cutaneous Malassezia: Commensal, Pathogen, or Protector? Front Cell Infect Microbiol 2020;10:614446. [PMID: 33575223 DOI: 10.3389/fcimb.2020.614446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Scalise A, Falcone M, Avruscio G, Brocco E, Ciacco E, Parodi A, Tasinato R, Ricci E. What COVID-19 taught us: New opportunities and pathways from telemedicine and novel antiseptics in wound healing. Int Wound J 2021. [PMID: 34599861 DOI: 10.1111/iwj.13695] [Reference Citation Analysis]
5 Chopra T, Sandhu A, Theriault N, Meehan J, Tillotson G. Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Future Microbiol 2020;15:1319-33. [PMID: 32959689 DOI: 10.2217/fmb-2020-0182] [Reference Citation Analysis]
6 Overcash JS, Kim C, Keech R, Gumenchuk I, Ninov B, Gonzalez-Rojas Y, Waters M, Simeonov S, Engelhardt M, Saulay M, Ionescu D, Smart JI, Jones ME, Hamed KA. Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET). Clin Infect Dis 2021;73:e1507-17. [PMID: 32897367 DOI: 10.1093/cid/ciaa974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu Y, She P, Xu L, Chen L, Li Y, Liu S, Li Z, Hussain Z, Wu Y. Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus. Front Microbiol 2021;12:727692. [PMID: 34489917 DOI: 10.3389/fmicb.2021.727692] [Reference Citation Analysis]
8 Chao CM, Weng TS, Chen YH, Lai CC, Lin WT. Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2021;:1-7. [PMID: 34753366 DOI: 10.1080/14787210.2022.2004119] [Reference Citation Analysis]
9 Mehanna MM, Mneimneh AT, Abed El Jalil K. Levofloxacin-loaded naturally occurring monoterpene-based nanoemulgel: a feasible efficient system to circumvent MRSA ocular infections. Drug Dev Ind Pharm 2020;46:1787-99. [PMID: 32896171 DOI: 10.1080/03639045.2020.1821048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Stefanov SR, Andonova VY. Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals (Basel) 2021;14:1083. [PMID: 34832865 DOI: 10.3390/ph14111083] [Reference Citation Analysis]
11 Bloem A, Bax HI, Yusuf E, Verkaik NJ. New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis. J Clin Med 2021;10:1743. [PMID: 33920526 DOI: 10.3390/jcm10081743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Scott LJ. Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. Drugs 2020;80:1247-58. [PMID: 32666425 DOI: 10.1007/s40265-020-01358-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Preda-Naumescu A, Elewski B, Mayo TT. Common Cutaneous Infections: Patient Presentation, Clinical Course, and Treatment Options. Med Clin North Am 2021;105:783-97. [PMID: 34059250 DOI: 10.1016/j.mcna.2021.04.012] [Reference Citation Analysis]
14 Karpuz M, Atlihan-Gundogdu E, Demir ES, Senyigit Z. Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity. AAPS PharmSciTech 2021;22:62. [PMID: 33528714 DOI: 10.1208/s12249-020-01917-4] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wittke F, Vincent C, Chen J, Heller B, Kabler H, Overcash JS, Leylavergne F, Dieppois G. Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid. Antimicrob Agents Chemother 2020;64:e00250-20. [PMID: 32747361 DOI: 10.1128/AAC.00250-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Bassetti M, Del Puente F, Magnasco L, Giacobbe DR. Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials. Expert Opin Investig Drugs 2020;29:495-506. [PMID: 32242469 DOI: 10.1080/13543784.2020.1750595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Dash HR, Das S. Thanatomicrobiome and epinecrotic community signatures for estimation of post-mortem time interval in human cadaver. Appl Microbiol Biotechnol 2020;104:9497-512. [PMID: 33001249 DOI: 10.1007/s00253-020-10922-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
18 Moran GJ, Chitra S, Mcgovern PC. Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs. Infect Dis Ther. [DOI: 10.1007/s40121-021-00587-4] [Reference Citation Analysis]
19 Vlachaki I, Vacchelli M, Zinzi D, Falla E, Jiang Y, Mantopoulos T, Nathwani D. Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis. BMC Infect Dis 2021;21:1036. [PMID: 34610820 DOI: 10.1186/s12879-021-06736-x] [Reference Citation Analysis]
20 Giacobbe DR, Labate L, Vena A, Bassetti M. Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections. Curr Opin Infect Dis 2021;34:109-17. [PMID: 33395093 DOI: 10.1097/QCO.0000000000000708] [Reference Citation Analysis]
21 Pai MP, Wilcox MH, Chitra S, McGovern PC. Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections. J Antimicrob Chemother 2021;76:1315-22. [PMID: 33458763 DOI: 10.1093/jac/dkaa558] [Reference Citation Analysis]
22 Dodero A, Scarfi S, Mirata S, Sionkowska A, Vicini S, Alloisio M, Castellano M. Effect of Crosslinking Type on the Physical-Chemical Properties and Biocompatibility of Chitosan-Based Electrospun Membranes. Polymers (Basel) 2021;13:831. [PMID: 33803084 DOI: 10.3390/polym13050831] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]